Drugs: Pressemitteilungen - Kategorie - Seite 14

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Cleveland BioLabs Reports 2015 Financial Results and Development Progress

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/22/16 -- (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and year ended December 31, 2015.Cleveland BioLabs reported ...

Marina Biotech Announces Evaluation and Option Agreement to Deliver a Genome Editing Technology

BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 02/18/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases announced today that they ...

Marina Biotech to Explore Strategic Alternatives

BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 02/17/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its ...

Knight Breaks Glass on Medimetriks Partnership

MONTREAL, CANADA and NEW JERSEY, UNITED STATES: MONTREAL, CANADA and NEW JERSEY, UNITED STATES -- (Marketwired) -- 02/17/16 -- Knight Therapeutics Inc. (TSX: GUD) (Knight) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) announced today that K ...

Medivation Announces Fourth Quarter and Year-End 2015 Financial Results Teleconference on February 25, 2016

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 02/11/16 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss fourth quarter and year-end 2015 f ...

Tergus Hires Top Manufacturing Executive

SAN FRANCISCO, CA: Ashik Pavagadhi Will Take on Head of Manufacturing Operations role ...

Sermonix Pharmaceuticals to Give Two Lasofoxifene Presentations at International Society for the Study of Women's Sexual Health Meeting

COLUMBUS, OH: COLUMBUS, OH -- (Marketwired) -- 02/10/16 -- Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's heal ...

Flamel Technologies Acquires FSC Pediatrics

LYON, FRANCE: Diversifies Product Portfolio and Brings Established Commercial Infrastructure; Revised Full Year 2016 Revenue Guidance of $110 to $130 Million; Conference Call Today at 5:30 pm ET to Discuss the Tran ...

Acasti Announces Share-for-Debt

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 02/05/16 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: APO), an emerging biopharmaceutical company focused o ...

Innoviva Reports Fourth Quarter and Full Year 2015 Financial Results

SOUTH SAN FRANCISCO, CA: Company Reports Its First Quarterly Net Income, Generating $4.3 Million in Q4 2015; Repurchased Approximately $37 Million of Stock Through the End of January 2016; Company to Host Conference Call and ...

West to Present at LEERINK Conference

EXTON, PA: EXTON, PA -- (Marketwired) -- 02/03/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at the LEERINK Partners ...

Medgenics Promotes Brian Piper to Chief Financial Officer

PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 02/03/16 -- (NYSE MKT: MDGN) today announced that Brian Piper will become the Company's new Chief Financial Officer effective February 9, 2016. Mr. Piper joi ...

Braeburn Pharmaceuticals and Knight Therapeutics Announce Canadian Sublicense Agreement for PROBUPHINE(R)

PRINCETON, NEW JERSEY and MONTREAL, QUEBEC: PRINCETON, NEW JERSEY and MONTREAL, QUEBEC -- (Marketwired) -- 02/01/16 -- Braeburn Pharmaceuticals, Inc. ("Braeburn") and Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leadi ...

Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis

CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 02/01/16 -- Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan a ...

Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 01/29/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and comm ...

Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial Results, Provides 2016 Revenue Guidance and Corporate Update

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/28/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, dev ...

MSI Methylation Sciences Inc. (MSI) Announces Results From the Horizon Phase 2 Trial for its Novel Treatment, MSI-195, for Major Depressive Disorder (MDD)

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/27/16 -- MSI Methylation Sciences Inc., a pharmaceutical company developing oral, small molecule therapies for major depressive disorder (MDD), ann ...

Innoviva to Report Fourth Quarter and Full Year 2015 Financial Results on February 3, 2016

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/27/16 -- Innoviva, Inc. (NASDAQ: INVA) announced today that it will report financial results for the fourth quarter and full year ended December 31, 201 ...

INTEGA Skin Looks GUD to Knight

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 01/25/16 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has entered in ...


Seite 15 von 66:  « ..  14 15 16  17  18  19  20  21  22  23  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z